Pitcairn’s Boston Scientific BSX Stock Holding History

Pitcairn’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,187	Closed	-$1.48M	–	83
2025 Q3	$1.48M	Sell	15,187 -4,159	-21%	-$431K	0.12%	157
2025 Q2	$2.08M	Sell	19,346 -4,291	-18%	-$434K	0.14%	141
2025 Q1	$2.38M	Buy	23,637 +2,307	+11%	+$232K	0.14%	130
2024 Q4	$1.91M	Buy	21,330 +682	+3%	+$60K	0.11%	168
2024 Q3	$1.73M	Buy	20,648 +2,579	+14%	+$203K	0.1%	181
2024 Q2	$1.39M	Buy	18,069 +11,460	+173%	+$839K	0.09%	220
2024 Q1	$453K	Sell	6,609 -409	-6%	-$26.3K	0.03%	458
2023 Q4	$406K	Sell	7,018 -57	-0.8%	-$3.04K	0.03%	455
2023 Q3	$374K	Buy	7,075 +727	+11%	+$38.1K	0.03%	443
2023 Q2	$343K	Buy	6,348 +90	+1%	+$4.7K	0.03%	473
2023 Q1	$313K	Buy	6,258 +1,340	+27%	+$63.2K	0.03%	477
2022 Q4	$228K	Buy	+4,918	New	+$213K	0.02%	534
2022 Q2	–	Sell	-4,724	Closed	-$209K	–	581
2022 Q1	$209K	Buy	+4,724	New	+$205K	0.02%	587
2021 Q4	–	Sell	-4,715	Closed	-$205K	–	630
2021 Q3	$205K	Buy	4,715 +32	+0.7%	+$1.42K	0.01%	598
2021 Q2	$200K	Buy	+4,683	New	+$197K	0.01%	597

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pitcairn's BSX Position: Q4 2025 in Review

Pitcairn sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 15,187 shares — an estimated $1.48M sold.

Pitcairn first reported a position in BSX in Q2 2021 and held it in 15 quarters. The position peaked at $2.38M in Q1 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Pitcairn reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Pitcairn sold 15,187 Boston Scientific shares in Q4 2025, an estimated $1.48M.
Pitcairn first reported a position in Boston Scientific in Q2 2021 and held it in 15 quarters.
Pitcairn's Boston Scientific position peaked at $2.38M in Q1 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.